These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1342291)

  • 1. Lipoprotein(a). Link between structure and pathology.
    Scanu AM
    Ann Epidemiol; 1992 Jul; 2(4):407-12. PubMed ID: 1342291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a): structural implications for pathophysiology.
    Koschinsky ML; Marcovina SM
    Int J Clin Lab Res; 1997; 27(1):14-23. PubMed ID: 9144023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process.
    Anglés-Cano E
    Braz J Med Biol Res; 1997 Nov; 30(11):1271-80. PubMed ID: 9532233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a), atherosclerosis and thrombosis.
    Dahlén GH
    Prog Lipid Res; 1991; 30(2-3):189-94. PubMed ID: 1840453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis.
    Scanu AM
    Arch Pathol Lab Med; 1988 Oct; 112(10):1045-7. PubMed ID: 2972266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) and atherosclerosis.
    Scanu AM; Lawn RM; Berg K
    Ann Intern Med; 1991 Aug; 115(3):209-18. PubMed ID: 1829339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis and pathophysiological implications of high plasma Lp(a) levels.
    Scanu AM
    J Intern Med; 1992 Jun; 231(6):679-83. PubMed ID: 1535652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a): an emerging cardiovascular risk factor.
    Lippi G; Guidi G
    Crit Rev Clin Lab Sci; 2003 Feb; 40(1):1-42. PubMed ID: 12627747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
    Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
    Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipoprotein (a): a genetic risk factor with atherogenic and thrombogenic properties].
    Vaverková H; Novotný D
    Vnitr Lek; 1995 Sep; 41(9):618-23. PubMed ID: 7483354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role.
    Scanu AM
    Mol Cell Biochem; 1992 Aug; 113(2):127-31. PubMed ID: 1387699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma triglyceride levels shift lipoprotein(a) density in parallel with that of LDL independently of apolipoprotein(a) size.
    Nakajima K; Hinman J; Pfaffinger D; Edelstein C; Scanu AM
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1238-43. PubMed ID: 11451758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lp(a) as a marker for coronary heart disease risk.
    Scanu AM
    Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I35-9. PubMed ID: 1828399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits.
    Ichikawa T; Unoki H; Sun H; Shimoyamada H; Marcovina S; Shikama H; Watanabe T; Fan J
    Am J Pathol; 2002 Jan; 160(1):227-36. PubMed ID: 11786416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein (a): implication in atherothrombosis.
    Chapman MJ; Huby T; Nigon F; Thillet J
    Atherosclerosis; 1994 Oct; 110 Suppl():S69-75. PubMed ID: 7857388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherothrombogenicity of lipoprotein(a): the debate.
    Scanu AM
    Am J Cardiol; 1998 Nov; 82(9A):26Q-33Q. PubMed ID: 9819101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of lipoprotein (a): growing complexities.
    Klezovitch O; Scanu AM
    Curr Opin Lipidol; 1995 Aug; 6(4):223-8. PubMed ID: 7670751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of lipoprotein (a) and high density lipoproteins in transgenic mice.
    Rubin EM
    Atherosclerosis; 1994 Oct; 110 Suppl():S77-81. PubMed ID: 7857389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lipoprotein(a) in atherogenesis and thrombosis.
    Hajjar KA; Nachman RL
    Annu Rev Med; 1996; 47():423-42. PubMed ID: 8712793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.